Filter posts

Patent Reform Needs to Address Trolling of All Stripes

As we enter the final days of the 114th Congress, it is regrettable that the …

"II Ca-Be-lly, or Not II Ca-Be-lly?”: Is The Famous Cabilly II Antibody Patent Near Extinction?

Guest post by Konstantin Linnik, Ph.D., Isaac Hubner, Ph.D, and Lana Gladstein, who are attorneys …

Patent Reform in the News

The New York Post and The Washington Post have both run Op-eds in the last week addressing …

Politicking Biopharma Delays Cures

Forbes’ Matthew Herper ran a guest post from Robert Nelsen, cofounder and managing director of …

PTAB Ruling Proves Medical Innovation Under Attack

There’s more evidence today that the IPR system needs to be fixed. PTAB ruled on …

BIO on CNBC: IPR System Weakens Medical Innovation

Last night Ron Cohen, M.D., CEO of Acorda Therapeutics and BIO’s board chair, appeared on …

Here are the Facts about the IPR Kill Rate

FiercePhrma recently ran an article repeating a dubious analysis of the crisis caused by the …

102 Organizations Urge Congress to Maintain a Strong Patent System and Protect Innovation

A diverse group of more than 100 national and state-based advocacy organizations have united to …

CNBC Commentary: Hedge funds, 'reverse trolls' crushing biopharma innovation

Patents are the lifeblood of medical innovation. They are the cornerstone that enables companies to …

This Independence Day, Let’s Thank the Inventors

Happy Birthday AMERICA! That’s right, this Saturday is July 4. And yes, that means what …